Details for New Drug Application (NDA): 019486
✉ Email this page to a colleague
NDA 019486 describes DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER, which is a drug marketed by Abbott, Fresenius Kabi Usa, Icu Medical Inc, Miles, and B Braun, and is included in six NDAs. It is available from two suppliers. Additional details are available on the DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER profile page.
The generic ingredient in DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER is dextrose; sodium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; sodium chloride profile page.
The generic ingredient in DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER is dextrose; sodium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; sodium chloride profile page.
Summary for 019486
| Tradename: | DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER |
| Applicant: | Abbott |
| Ingredient: | dextrose; sodium chloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5GM/100ML;300MG/100ML | ||||
| Approval Date: | Oct 4, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
